Company Email Format Management

Imbria Pharmaceuticals

Biotechnology Research 265 Franklin Street 13 employees

Employees: 13
Contacts: 2
Emails: 2
Phones: 1

imbria.com LinkedIn Crunchbase

Imbria Pharmaceuticals Overview

Headquarters: 265 Franklin Street
Website: imbria.com
Industry: Biotechnology Research
Employees: 13
Founded: 2018
Funding: 59.2M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Imbria Pharmaceuticals

Imbria is a privately held, clinical stage company developing novel therapies for patients with life-altering cardiometabolic disorders. Our clinical stage pipeline is focused on restoring or improving the cell’s ability to produce energy in cardiovascular disorders where energetic impairment is a fundamental contributor to symptoms and functional deficits. The lead product candidate, ninerafaxstat, is currently in Phase 2 clinical development in three indications: nHCM, stable angina, and HFpEF. For additional information, please visit www.imbria.com.

Imbria Pharmaceuticals Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Imbria Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Malisa Heiman	Administration - Operations		View
Alvin Shih	Biotech Executive and Board Member	United States	Email Phone
Komal Joshi	Chief Financial Officer at Imbria		View
James Januzzi	Adolph Hutter Professor of Medicine	Greater Boston, United States	Email